Epigenetic regulation of Fructose-1,6-bisphosphatase 1 by host transcription factor Speckled 110 kDa during hepatitis B virus infection
- PMID: 35653238
- DOI: 10.1111/febs.16544
Epigenetic regulation of Fructose-1,6-bisphosphatase 1 by host transcription factor Speckled 110 kDa during hepatitis B virus infection
Abstract
Hepatitis B virus (HBV) is the leading cause of liver disease ranging from acute and chronic hepatitis to liver cirrhosis and hepatocellular carcinoma (HCC). Studies have revealed that HBV infection broadly reprogrammes the host cellular metabolic processes for viral pathogenesis. Previous reports have shown that glycolysis and gluconeogenesis are among the most deregulated pathways during HBV infection. We noted that despite being one of the rate-limiting enzymes of gluconeogenesis, the role and regulation of Fructose-1,6-bisphosphatase 1 (FBP1) during HBV infection is not much explored. In this study, we report FBP1 upregulation upon HBV infection and unravel a novel mechanism of epigenetic reprogramming of FBP1 by HBV via utilizing host factor Speckled 110 kDa (Sp110). Here, we identified acetylated lysine 18 of histone H3 (H3K18Ac) as a selective interactor of Sp110 Bromodomain. Furthermore, we found that Sp110 gets recruited on H3K18Ac-enriched FBP1 promoter, and facilitates recruitment of deacetylase Sirtuin 2 (SIRT2) on that site in the presence of HBV. SIRT2 in turn brings its interactor and transcriptional activator Hepatocyte nuclear factor 4-alpha to the promoter, which ultimately leads to a loss of DNA methylation near the cognate site. Interestingly, this Sp110 driven FBP1 regulation during infection was found to promote viral-borne HCC progression. Moreover, Sp110 can be used as a prognostic marker for the hepatitis-mediated HCC patients, where high Sp110 expression significantly lowered their survival. Thus, the epigenetic reader protein Sp110 has potential to be a therapeutic target to challenge HBV-induced HCCs.
Keywords: Fructose-1,6-bisphosphatase; Speckled 110 kDa; epigenetics; gluconeogenesis; hepatitis B virus; hepatocellular carcinoma.
© 2022 Federation of European Biochemical Societies.
Similar articles
-
Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence.J Biol Chem. 2017 Dec 15;292(50):20379-20393. doi: 10.1074/jbc.M117.796839. Epub 2017 Oct 18. J Biol Chem. 2017. PMID: 29046350 Free PMC article.
-
UBR7 E3 Ligase Suppresses Interferon-β Mediated Immune Signaling by Targeting Sp110 in Hepatitis B Virus-Induced Hepatocellular Carcinoma.ACS Infect Dis. 2024 Nov 8;10(11):3775-3796. doi: 10.1021/acsinfecdis.4c00213. Epub 2024 Jun 28. ACS Infect Dis. 2024. PMID: 38938101
-
An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.J Virol. 2020 Jul 30;94(16):e00926-20. doi: 10.1128/JVI.00926-20. Print 2020 Jul 30. J Virol. 2020. PMID: 32493816 Free PMC article.
-
Decoding the multifaceted interventions between human sirtuin 2 and dynamic hepatitis B viral proteins to confirm their roles in HBV replication.Front Cell Infect Microbiol. 2024 Jan 4;13:1234903. doi: 10.3389/fcimb.2023.1234903. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38239506 Free PMC article. Review.
-
The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.Front Immunol. 2021 Apr 29;12:661204. doi: 10.3389/fimmu.2021.661204. eCollection 2021. Front Immunol. 2021. PMID: 33995383 Free PMC article. Review.
Cited by
-
N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling.J Hepatocell Carcinoma. 2023 Nov 6;10:1991-2007. doi: 10.2147/JHC.S433070. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37954496 Free PMC article.
-
What role for cellular metabolism in the control of hepatitis viruses?Front Immunol. 2022 Nov 17;13:1033314. doi: 10.3389/fimmu.2022.1033314. eCollection 2022. Front Immunol. 2022. PMID: 36466918 Free PMC article. Review.
-
N6 -methyladenosine-modified FAM111A-DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A.Cancer Sci. 2023 Sep;114(9):3649-3665. doi: 10.1111/cas.15886. Epub 2023 Jul 3. Cancer Sci. 2023. PMID: 37400994 Free PMC article.
-
Inhibition of Histone H3K18 Acetylation-Dependent Antioxidant Pathways Involved in Arsenic-Induced Liver Injury in Rats and the Protective Effect of Rosa roxburghii Tratt Juice.Toxics. 2023 Jun 3;11(6):503. doi: 10.3390/toxics11060503. Toxics. 2023. PMID: 37368603 Free PMC article.
-
Restoring gluconeogenesis by TEF inhibited proliferation and promoted apoptosis and immune surveillance in kidney renal clear cell carcinoma.Cancer Metab. 2023 Aug 8;11(1):11. doi: 10.1186/s40170-023-00312-4. Cancer Metab. 2023. PMID: 37553601 Free PMC article.
References
-
- Mhamdi M, Funk A, Hohenberg H, Will H, Sirma H. Assembly and budding of a hepatitis B virus is mediated by a novel type of intracellular vesicles. Hepatology. 2007;46:95-106.
-
- Hu L, Chen L, Li L, Sun H, Yang G, Chang Y, et al. Hepatitis B virus X protein enhances cisplatin-induced hepatotoxicity via a mechanism involving degradation of Mcl-1. J Virol. 2011;85:3214-28.
-
- Zhang T, Xie N, He W, Liu R, Lei Y, Chen Y, et al. An integrated proteomics and bioinformatics analyses of hepatitis B virus X interacting proteins and identification of a novel interactor apoA-I. J Proteomics. 2013;84:92-105.
-
- Masson JJR, Billings HWW, Palmer CS. Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities. Antivir Chem Chemother. 2017;25:53-7.
-
- Liu B, Fang M, He Z, Cui D, Jia S, Lin X, et al. Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation. Cell Death Dis. 2015;6:e1980.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous